Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sun Pharma Advanced Research Co. Ltd. ( (IN:SPARC) ) has provided an announcement.
Sun Pharma Advanced Research Company Limited has notified stock exchanges that it has published public notices convening an Extra Ordinary General Meeting (EGM) of shareholders through advertisements in multiple editions of the Financial Express in English and Gujarati. The company states that the advertisements follow the emailing of the EGM notice to shareholders whose email addresses are on record, and that these steps are in line with disclosure and publication requirements under SEBI’s Listing Obligations and Disclosure Requirements Regulations, underscoring SPARC’s adherence to regulatory norms and transparency in shareholder communication.
More about Sun Pharma Advanced Research Co. Ltd.
Sun Pharma Advanced Research Company Limited (SPARC) is a pharmaceutical research and development company focused on creating and developing novel and differentiated formulations and delivery systems, primarily in specialty and innovative therapies. It operates within the broader healthcare and life sciences sector, supporting the pipeline of parent and partner companies with advanced drug research aimed at regulated and emerging markets.
Average Trading Volume: 567,570
Technical Sentiment Signal: Sell
Current Market Cap: 43.96B INR
See more data about SPARC stock on TipRanks’ Stock Analysis page.